Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering

Organogenesis

Volumn 4, Issue 4, 2008, Pages 203-214

  Pardue, Erin L ^a   Ibrahim, Samir ^a   Ramamurthi, Anand ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

Angiogenesis; Hyaluronan; Neo vascularization; Oligosaccharides; Regenerative medicine; Tissue engineering

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENIN; ANGIOPOIETIN 1; ANGIOSTATIN; ANTITHROMBIN III; BASIC FIBROBLAST GROWTH FACTOR; ENDOSTATIN; FOLLISTATIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN LYASE; HYALURONIC ACID; INTERLEUKIN 12; INTERLEUKIN 18; LEPTIN; METALLOPROTEINASE INHIBITOR; MIDKINE; PLACENTAL GROWTH FACTOR; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLEIOTROPHIN; POLYANHYDRIDE; POLYCAPROLACTONE; PROGRANULIN; SCATTER FACTOR; THROMBOCYTE FACTOR 4; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR; UNINDEXED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; BIOLOGICAL ACTIVITY; CARBOHYDRATE ANALYSIS; CONNECTIVE TISSUE; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL; HUMAN; IN VIVO STUDY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; REVIEW; STIMULATION; TISSUE ENGINEERING; TISSUE NECROSIS;

EID: 57349115398     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.4.4.6926     Document Type: Review

References (134)

1. Folkman J. Toward an understanding of angiogenesis: search and discovery. Perspect Biol Med 1985; 29:10-36.
2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-64.
3. Laschke MW, Harder Y, Amon M, et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 2006; 12:2093-104.
4. Arnold F, West DC. Angiogenesis in wound healing. Pharmacol Ther 1991; 52:407-22.
5. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. Integrin alphavbeta3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994; 79:1157-64.
6. Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, Colotta F. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 1994; 127:537-46.
7. Isner JM. Cancer and atherosclerosis: the broad mandate of angiogenesis. Circulation 1999; 99:1653-5.
8. Colton CK. Implantable biohybrid artificial organs. Cell Transplant 1995; 4:415-36.
9. Folkman J, Hochberg M. Self-regulation of growth in three dimensions. J Exp Med 1973; 138:745-53.
10. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. Hypoxia-induced tumor angiogenic pathway in head and neck cancer: an in vivo study. Cancer Lett 2005; 225:297-304.
11. Distler O, Neidhart M, Gay RE, Gay S. The molecular control of angiogenesis. Int Rev Immunol 2002; 21:33-49.
12. Karamysheva AF. Mechanisms of angiogenesis. Biochemistry (Mosc) 2008; 73:751-62.
13. Ratajska A, Czarnowska E, Kolodzinska A, Kluzek W, Lesniak W. Vasculogenesis of the embryonic heart: origin of blood island-like structures. Anat Rec A Discov Mol Cell Evol Biol 2006; 288:223-32.
14. Masuda H, Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc Res 2003; 58:390-8.
15. Tepper OM, Capla JM, Galiano RD, Ceradini DJ, Callaghan MJ, Kleinman ME, Gurtner GC. Adult vasculogenesis occurs through in situ recruitment, proliferation and tubulization of circulating bone marrow-derived cells. Blood 2005; 105:1068-77.
16. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000; 97:3422-7.
17. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7:430-6.
18. Kawamoto A, Asahara T, Losordo DW. Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med 2002; 3:221-5.
19. Enciso JM, Hirschi KK. Nutrient regulation of tumor and vascular endothelial cell proliferation. Curr Cancer Drug Targets 2007; 7:432-7.
20. Stupack DG, Cheresh DA. Apoptotic cues from the extracellular matrix: regulators of angiogenesis. Oncogene 2003; 22:9022-9.
21. Polverini PJ, Leibovich SJ. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 1984; 51:635-42.
22. Canfield AE, Schor AM, Schor SL, Grant ME. The biosynthesis of extracellular-matrix components by bovine retinal endothelial cells displaying distinctive morphological phenotypes. Biochem J 1986; 235:375-83.
23. Niedbala MJ. Cytokine regulation of endothelial cell extracellular proteolysis. Agents Actions Suppl 1993; 42:179-93.
24. Madri JA, Pratt BM, Tucker AM. Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 1988; 106:1375-84.
25. Maragoudakis ME, Sarmonika M, Panoutsacopoulou M. Inhibition of basement membrane biosynthesis prevents angiogenesis. J Pharmacol Exp Ther 1988; 244:729-33.
26. Zhang YW, Su Y, Volpert OV, Vande Woude GF. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci USA 2003; 100:12718-23.
27. Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 1989; 56:345-55.
28. Polverini PJ. The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995; 6:230-47.
29. Bauland CG, van Steensel MA, Steijlen PM, Rieu PN, Spauwen PH. The pathogenesis of hemangiomas: a review. Plast Reconstr Surg 2006; 117:29-35.
30. Heidenreich R, Röcken M, Ghoreschi K. Angiogenesis: the new potential target for the therapy of psoriasis? Drug News Perspect 2008; 21:97-105.
31. Velasco P, Lange-Asschenfeldt B. Dermatological aspects of angiogenesis. Br J Dermatol 2002; 147:841-52.
32. Simó R, Carrasco E, García-Ramírez M, Hernández C. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy. Curr Diabetes Rev 2006; 2:71-98.
33. Laschke MW, Menger MD. In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 2007; 13:331-42.
34. Fearon U, Veale DJ. Angiogenesis in arthritis: methodological and analytical details. Methods Mol Med 2007; 135:343-57.
35. Sluimer JC, Gasc JM, van Wanroij JL, Kisters N, Groeneweg M, Sollewijn Gelpke MD, Cleutjens JP, van den Akker LH, Corvol P, Wouters BG, Daemen MJ, Bijnens AP. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 2008; 51:1258-65.
36. Fukumura D, Jain RK. Tumor microvasculature and microenvironment: targets for antiangiogenesis and normalization. Microvasc Res 2007; 74:72-84.
37. Jayasankar V, Woo YJ, Pirolli TJ, Bish LT, Berry MF, Burdick J, Gardner TJ, Sweeney HL. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure. J Card Surg 2005; 20:93-101.
38. Hausman MR, Rinker BD. Intractable wounds and infections: the role of impaired vascularity and advanced surgical methods for treatment. Am J Surg 2004; 187:44-55.
39. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260:920-6.
40. Nomi M, Miyake H, Sugita Y, Fujisawa M, Soker S. Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering. Curr Stem Cell Res Ther 2006; 1:333-43.
41. Steffens L, Wenger A, Stark GB, Finkenzeller G. In vivo engineering of a human vasculature for bone tissue engineering applications. J Cell Mol Med 2008; in press.
42. Finkenzeller G, Torio-Padron N, Momeni A, Mehlhorn AT, Stark GB. In vitro angiogenesis properties of endothelial progenitor cells: a promising tool for vascularization of ex vivo engineered tissues. Tissue Eng 2007; 13:1413-20.
43. Jang JH, Kim SK, Choi JE, Kim YJ, Lee HW, Kang SY, Park JS, Choi JH, Lim HY, Kim HC. Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells. Acta Pharmacol Sin 2007; 28:367-74.
44. Bouis D, Kusumanto Y, Meijer C, Mulder NH, Hospers GA. A review on pro- and antiangiogenic factors as targets of clinical intervention. Pharmacol Res 2006; 53:89-103.
45. Soker S, Machado M, Atala A. Systems for therapeutic angiogenesis in tissue engineering. World J Urol 2000; 18:10-8.
46. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407:242-8.
47. Morishita R, Aoki M, Hashiya N, et al. Therapeutic angiogenesis using hepatocyte growth factor (HGF). Curr Gene Ther 2004; 4:199-206.
48. Vashi AV, Abberton KM, Thomas GP, et al. Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix. Tissue Eng 2006; 12:3035-43.
49. Kontos CD, Annex BH. Engineered transcription factors for therapeutic angiogenesis. Curr Opin Mol Ther 2007; 9:145-52.
50. Landman KA, Cai AQ. Cell proliferation and oxygen diffusion in a vascularising scaffold. Bull Math Biol 2007; 69:2405-28.
51. Butler MJ, Sefton MV. Poly(butyl methacrylate-co-methacrylic acid) tissue engineering scaffold with pro-angiogenic potential in vivo. J Biomed Mater Res A 2007; 82:265-73.
52. Druecke D, Langer S, Lamme E, Pieper J, Ugarkovic M, Steinau HU, Homann HH. Neovascularization of poly(ether ester) block-copolymer scaffolds in vivo: long-term investigations using intravital fluorescent microscopy. J Biomed Mater Res A 2004; 68:10-8.
53. Bakshi A, Fisher O, Dagci T, Himes BT, Fischer I, Lowman A. Mechanically engineered hydrogel scaffolds for axonal growth and angiogenesis after transplantation in spinal cord injury. J Neurosurg Spine 2004; 1:322-9.
54. Sung HJ, Meredith C, Johnson C, Galis ZS. The effect of scaffold degradation rate on threedimensional cell growth and angiogenesis. Biomaterials 2004; 25:5735-42.
55. Rücker M, Laschke MW, Junker D, Carvalho C, Tavassol F, Mülhaupt R, Gellrich NC, Menger MD. Vascularization and biocompatibility of scaffolds consisting of different calcium phosphate compounds. J Biomed Mater Res A 2008; 86:1002-11.
56. Laurencin CT, Pierre-Jacques HM, Langer R. Toxicology and biocompatibility considerations in the evaluation of polymeric materials for biomedical applications. Clin Lab Med 1990; 10:549-70.
57. Peter SJ, Miller ST, Zhu G, Yasko AW, Mikos AG. In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res 1998; 41:1-7.
58. Narmoneva DA, Oni O, Sieminski AL, Zhang S, Gertler JP, Kamm RD, Lee RT. Self-assembling short oligopeptides and the promotion of angiogenesis. Biomaterials 2005;26:4837-46.
59. Callegari A, Bollini S, Iop L, et al. Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. Biomaterials 2007; 28:5449-61.
60. Hall H. Modified fibrin hydrogel matrices: both, 3D-scaffolds and local and controlled release systems to stimulate angiogenesis. Curr Pharm Des 2007; 13:3597-607.
61. Jeon O, Ryu SH, Chung JH, Kim BS. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release 2005; 105:249-59.
62. Daamen WF, Nillesen ST, Wismans RG, et al. A biomaterial composed of collagen and solubilized elastin enhances angiogenesis and elastic fiber formation without calcification. Tissue Eng Part A 2008; 14:349-60.
63. Doi K, Ikeda T, Marui A, et al. Enhanced angiogenesis by gelatin hydrogels incorporating basic fibroblast growth factor in rabbit model of hind limb ischemia. Heart Vessels 2007; 22:104-8.
64. Ishihara M, Obara K, Nakamura S, et al. Chitosan hydrogel as a drug delivery carrier to control angiogenesis. J Artif Organs 2006; 9:8-16.
65. Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res A 2003; 65:489-97.
66. Flynn L, Prestwich GD, Semple JL, Woodhouse KA. Adipose tissue engineering in vivo with adipose-derived stem cells on naturally derived scaffolds. J Biomed Mater Res A 2008; in press.
67. Schoenfelder M, Einspanier R. Expression of hyaluronan synthases and corresponding hyaluronan receptors is differentially regulated during oocyte maturation in cattle. Biol Reprod 2003; 69:269-77.
68. Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4:528-39.
69. Itano N, Kimata K. Mammalian hyaluronan synthases. IUBMB Life 2002; 54:195-9.
70. Slevin M, Krupinski J, Gaffney J, Matou S, West D, Delisser H, Savani RC, Kumar S. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 2007; 26:58-68.
71. Stern R. Hyaluronan catabolism: a new metabolic pathway. Eur J Cell Biol 2004; 83:317-25.
72. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985; 228:1324-6.
73. Slevin M, West D, Kumar P, Rooney P, Kumar S. Hyaluronan, angiogenesis and malignant disease. Int J Cancer 2004; 109:793-4
74. Noble PW. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 2002; 21:25-9.
75. Rooney P, Kumar S, Ponting J, Wang M. The role of hyaluronan in tumour neovascularization. Int J Cancer 1995; 60:632-6.
76. Lai PH, Chang Y, Chen SC, Wang CC, Liang HC, Chang WC, Sung HW. Acellular biological tissues containing inherent glycosaminoglycans for loading basic fibroblast growth factor promote angiogenesis and tissue regeneration. Tissue Eng 2006; 12:2499-508.
77. West DC, Kumar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 1989; 183:179-96.
78. Evanko SP, Johnson PY, Braun KR, Underhill CB, Dudhia J, Wight TN. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells. Arch Biochem Biophys 2001; 394:29-38
79. Deed R, Rooney P, Kumar P, et al. Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, highmolecular-weight hyaluronan. Int J Cancer 1997; 71:251-6.
80. Genasetti A, Vigetti D, Viola M, Karousou E, Moretto P, Rizzi M, Bartolini B, Clerici M, Pallotti F, De Luca G, Passi A. Hyaluronan and human endothelial cell behavior. Connect Tissue Res 2008; 49:120-3.
81. Gao F, Yang CX, Mo W, Liu YW, He YQ. Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing. Clin Invest Med 2008; 31:106-16.
82. Montesano R, Kumar S, Orci L, Pepper MS. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest 1996; 75:249-62.
83. Chajara A, Raoudi M, Delpech B, Levesque H. Inhibition of arterial cells proliferation in vivo in injured arteries by hyaluronan fragments. Atherosclerosis 2003; 171:15-9.
84. Chajara A, Raoudi M, Delpech B, Levesque H. The fibroproliferative response of arterial smooth muscle cells to balloon catheter injury is associated with increased hyaluronidase production and hyaluronan degradation. Atherosclerosis 2001; 157:293-300.
85. Slevin M, Krupinski J, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest 1998; 78:987-1003.
86. Slevin M, Kumar S, Gaffney J. Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 2002; 277:41046-59.
87. Sattar A, Rooney P, Kumar S, et al. Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol 1994; 103:576-9.
88. Lees VC, Fan TP, West DC. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab Invest 1995; 73:259-66.
89. Sattar A, Kumar S, West DC. Does hyaluronan have a role in endothelial cell proliferation of the synovium? Semin Arthritis Rheum 1992; 22:37-43.
90. West DC, Kumar S. Endothelial cell proliferation and diabetic retinopathy. Lancet 1988;1: 715-6.
91. Ohno-Nakahara M, Honda K, Tanimoto K, Tanaka N, Doi T, Suzuki A, Yoneno K, Nakatani Y, Ueki M, Ohno S, Knudson W, Knudson CB, Tanne K. Induction of CD44 and MMP expression by hyaluronidase treatment of articular chondrocytes. J Biochem 2004;135:567-75.
92. Zhang Y, Thant AA, Machida K, Ichigotani Y, Naito Y, Hiraiwa Y, Senga T, Sohara Y, Matsuda S, Hamaguchi M. Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res 2002;62:3962-5.
93. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGFbeta and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14:163-76.
94. Lokeshwar VB, Selzer MG. Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel and vein-derived human endothelial cells. J Biol Chem 2000;275:27641-9.
95. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 2001; 276:36770-8.
96. Murphy JF, Lennon F, Steele C, Kelleher D, Fitzgerald D, Long AC. Engagement of CD44 modulates cyclooxygenase induction, VEGF generation and proliferation in human vascular endothelial cells. FASEB J 2005; 19:446-8.
97. Rodgers LS, Lalani S, Hardy KM, et al. Depolymerized hyaluronan induces vascular endothelial growth factor, a negative regulator of developmental epithelial-to-mesenchymal transformation. Circ Res 2006; 99:583-9.
98. Carson DD, Dutt A, Tang JP. Glycoconjugate synthesis during early pregnancy: hyaluronate synthesis and function. Dev Biol 1987; 120:228-35.
99. Lovvorn HN, 3rd, Cass DL, Sylvester KG, et al. Hyaluronan receptor expression increases in fetal excisional skin wounds and correlates with fibroplasia. J Pediatr Surg 1998;33:1062-9.
100. Dechert TA, Ducale AE, Ward SI, Yager DR. Hyaluronan in human acute and chronic dermal wounds. Wound Repair Regen 2006; 14:252-8.
101. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL. Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 2004;279:17079-84.
102. Greenwald RA, Moak SA. Degradation of hyaluronic acid by polymorphonuclear leukocytes. Inflammation 1986; 10:15-30.
103. Yamazaki K, Fukuda K, Matsukawa M, et al. Reactive oxygen species depolymerize hyaluronan: involvement of the hydroxyl radical. Pathophysiology 2003; 9:215-20.
104. Cao G, Savani RC, Fehrenbach M, et al. Involvement of endothelial CD44 during in vivo angiogenesis. Am J Pathol 2006; 169:325-36.
105. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-6.
106. Folkman J, Cole P, Zimmerman S. Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg 1966; 164:491-502.
107. Fjeldstad K, Kolset SO. Decreasing the metastatic potential in cancers - Targeting the heparan sulfate proteoglycans. Curr Drug Targets 2005; 6:665-82.
108. Koyama H, Hibi T, Isogai Z, et al. Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol 2007; 170:1086-99.
109. West DC, Kumar S. Hyaluronan and angiogenesis. Ciba Found Symp 1989; 143:187-201.
110. Itano N, Sawai T, Miyaishi O, Kimata K. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res 1999; 59:2499-504.
111. Lokeshwar VB, Obek C, Soloway MS, Block NL. Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. Cancer Res 1997; 57:773-7.
112. Lokeshwar VB, Young MJ, Goudarzi G, et al. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. Cancer Res 1999; 59:4464-70.
113. Hautmann SH, Schroeder GL, Civantos F, et al. [Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]. Urologe A 2001; 40:121-6.
114. Paiva P, Van Damme MP, Tellbach M, Jones RL, Jobling T, Salamonsen LA. Expression patterns of hyaluronan, hyaluronan synthases and hyaluronidases indicate a role for hyaluronan in the progression of endometrial cancer. Gynecol Oncol 2005; 98:193-202.
115. Bot PT, Hoefer IE, Piek JJ, Pasterkamp G. Hyaluronic Acid: targeting immune modulatory components of the extracellular matrix in atherosclerosis. Curr Med Chem 2008; 15:786-91.
116. Ibrahim S, Ramamurthi A. Hyaluronic acid cues for functional endothelialization of vascular constructs. J Tissue Eng Regen Med 2008; 2:22-32.
117. Gao F, Cao M, Yang C, He Y, Liu Y. Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study. J Biomed Mater Res B Appl Biomater 2006; 78:385-92.
118. Deed R, Rooney P, Kumar P, Norton JD, Smith J, Freemont AJ, Kumar S. Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int J Cancer 1997; 71:251-6.
119. Joddar B, Ibrahim S, Ramamurthi A. Impact of delivery mode of hyaluronan oligomers on elastogenic responses of adult vascular smooth muscle cells. Biomaterials 2007; 28:3918-27.
120. Ibrahim S, Joddar B, Craps M, Ramamurthi A. A surface-tethered model to assess size-specific effects of hyaluronan (HA) on endothelial cells. Biomaterials 2007; 28:825-35.
121. Collier JH, Camp JP, Hudson TW, Schmidt CE. Synthesis and characterization of polypyr-role-hyaluronic acid composite biomaterials for tissue engineering applications. J Biomed Mater Res 50:574-84.
122. Baier Leach J, Bivens KA, Patrick CW Jr, Schmidt CE. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 2003; 82:578-89.
123. Jansen K, van der Werff JF, van Wachem PB, Nicolai JP, de Leij LF, van Luyn MJ. A hyaluronan-based nerve guide: in vitro cytotoxicity, subcutaneous tissue reactions, and degradation in the rat. Biomaterials 2004; 25483-9.
124. Flynn L, Prestwich GD, Semple JL, Woodhouse KA. Adipose tissue engineering in vivo with adipose-derived stem cells on naturally derived scaffolds. J Biomed Mater Res A 2008; in press.
125. Allingham PG, Brownlee GR, Harper GS, Pho M, Nilsson SK, Brown TJ. Gene expression, synthesis and degradation of hyaluronan during differentiation of 3T3-L1 adipocytes. Arch Biochem Biophys 2006; 452:83-91.
126. Tonello C, Zavan B, Cortivo R, Brun P, Panfilo S, Abatangelo G. In vitro reconstruction of human dermal equivalent enriched with endothelial cells. Biomaterials 2003; 24:1205-11.
127. Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R, Metz CN. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 2001; 15:2215-24.
128. Pinney E, Liu K, Sheeman B, Mansbridge J. Human three-dimensional fibroblast cultures express angiogenic activity. J Cell Physiol 2000; 183:74-82.
129. Fournier N, Doillon CJ. Biological molecule-impregnated polyester: an in vivo angiogenesis study. Biomaterials 1996; 17:1659-65.
130. Peattie RA, Nayate AP, Firpo MA, Shelby J, Fisher RJ, Prestwich GD. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials 2004; 25:2789-98.
131. Kim MH. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J Cell Biochem 2003; 89:529-38.
132. Peattie RA, Rieke ER, Hewett EM, Fisher RJ, Shu XZ, Prestwich GD. Dual growth factor-induced angiogenesis in vivo using hyaluronan hydrogel implants. Biomaterials 2006; 27:1868-75.
133. Riley CM, Fuegy PW, Firpo MA, Shu XZ, Prestwich GD, Peattie RA. Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosaminoglycan hydrogels. Biomaterials 2006; 27:5935-43.
134. Borselli C, Oliviero O, Battista S, Ambrosio L, Netti PA. Induction of directional sprouting angiogenesis by matrix gradients. J Biomed Mater Res A 2007; 80:297-305.